Your session is about to expire
← Back to Search
High vs Moderate Intensity Gait Training for Multiple Sclerosis
N/A
Recruiting
Research Sponsored by Hunter College of City University of New York
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up performed in the week before and the week after the intervention.
Awards & highlights
Study Summary
This trial will compare the effects of HIIGT vs MICGT in pwMS.
Who is the study for?
This trial is for adults over 18 with Multiple Sclerosis who can walk for 6 minutes, even if they need a device. They must be able to understand and sign a consent form. It's not open to those with heart/lung problems, other neurological or orthopedic conditions, or recent MS flare-ups.Check my eligibility
What is being tested?
The study compares two types of walking exercises: High Intensity Interval Gait Training (HIIGT) which mixes fast walking with rest periods, and Moderate Intensity Continuous Gait Training (MICGT), the usual slower-paced exercise.See study design
What are the potential side effects?
Potential side effects are not specified but may include fatigue, muscle soreness, joint pain due to increased physical activity especially in high-intensity training.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ the test will be administered to all subjects one week before and one week after the intervention.the test will be administered to all subjects one week before and one week after the intervention.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~the test will be administered to all subjects one week before and one week after the intervention.the test will be administered to all subjects one week before and one week after the intervention.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Six minute walk test time from before to after the intervention
Secondary outcome measures
Gait
Interventional procedure
Multiple Sclerosis
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: High Intensity Interval gait trainingExperimental Treatment1 Intervention
subjects will receive 3x/week high intensity interval training for 20 minutes over a 4 week period
Group II: Moderate intensity continuous gait trainingActive Control1 Intervention
subjects will receive 3x/week moderate intensity continuous gait training for 20 minutes over a 4 week period
Find a Location
Who is running the clinical trial?
Hunter College of City University of New YorkLead Sponsor
38 Previous Clinical Trials
9,005 Total Patients Enrolled
2 Trials studying Multiple Sclerosis
42 Patients Enrolled for Multiple Sclerosis
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You can walk continuously for 6 minutes with or without help.You have been diagnosed with multiple sclerosis.People who have been diagnosed with multiple sclerosis.You can walk continuously for 6 minutes, with or without help from a device.You have any heart, lung, bone, or non-MS nerve problems.You have had a recent worsening of your condition.
Research Study Groups:
This trial has the following groups:- Group 1: High Intensity Interval gait training
- Group 2: Moderate intensity continuous gait training
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Multiple Sclerosis Patient Testimony for trial: Trial Name: NCT05560880 — N/A
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
To what extent is participation being sought for this experiment?
"Affirmative. According to information found on clinicaltrials.gov, this medical trial is actively seeking volunteers; it was initially posted on September 1st 2022 and recently updated in October 5th 2022. The study requires 30 individuals at a single site to continue its operations."
Answered by AI
Are recruitment efforts still underway for this investigation?
"According to clinicaltrials.gov, this research project is currently enrolling volunteers and seeks participants. The trial was initially launched on September 1st 2022, with the most recent update being October 5th of the same year."
Answered by AI
Who else is applying?
What state do they live in?
Florida
California
Other
New York
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
How many prior treatments have patients received?
1
0
3+
What site did they apply to?
Hunter College
What questions have other patients asked about this trial?
What is the screening for this trial and how long is this trail for?
PatientReceived no prior treatments
Why did patients apply to this trial?
I have a gait problem due to M. S. I can go to Africa. I want to be able to walk into the Motherland.
PatientReceived 2+ prior treatments
I am only taking Ampyra, and am having a very hard time walking and lifting my left leg. I am also getting extremely tired when standing more than a couple of minutes.
PatientReceived 2+ prior treatments
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger